In July 2016, the U.S. Food and Drug Administration (FDA) published draft guidance outlining when drug companies should update a generic drug’s label after the brand name drug on which the generic is based has been withdrawn...more
Three Senate Democrats recently introduced a bill that seeks to hold company executives of a product maker or seller criminally liable for knowingly "failing to inform and warn of serious dangers" associated with a product....more
7/30/2014
/ Automotive Industry ,
C-Suite Executives ,
Consumer Product Safety Commission (CPSC) ,
Corporate Counsel ,
Corporate Officers ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Food and Drug Administration (FDA) ,
General Motors ,
Manufacturers ,
Personal Liability ,
Popular ,
Proposed Legislation